List of Excipients in API acetaminophen 250 mg and ibuprofen 125 mg tablets
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing acetaminophen 250 mg and ibuprofen 125 mg tablets
Detailed excipient profiles for acetaminophen 250 mg and ibuprofen 125 mg tablets
Excipient focus: CELLULOSE, MICROCRYSTALLINE
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL DIBEHENATE
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing GLYCERYL DIBEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing GLYCERYL DIBEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| MARKSANS PHARMA LIMITED | acetaminophen 250 mg and ibuprofen 125 mg tablets | 25000-080 |
| >Company | >Ingredient | >NDC |
acetaminophen 250 mg and ibuprofen 125 mg tablets drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | acetaminophen 250 mg and ibuprofen 125 mg tablets | 51672-4258 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links